CureVac NV
NASDAQ:CVAC

Watchlist Manager
CureVac NV Logo
CureVac NV
NASDAQ:CVAC
Watchlist
Price: 3 USD 1.35%
Market Cap: 672.9m USD
Have any thoughts about
CureVac NV?
Write Note

CureVac NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CureVac NV
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
CureVac NV
NASDAQ:CVAC
Revenue
€53.8m
CAGR 3-Years
3%
CAGR 5-Years
33%
CAGR 10-Years
N/A
BioNTech SE
NASDAQ:BNTX
Revenue
€3.8B
CAGR 3-Years
99%
CAGR 5-Years
97%
CAGR 10-Years
N/A
MorphoSys AG
XETRA:MOR
Revenue
€203.5m
CAGR 3-Years
18%
CAGR 5-Years
18%
CAGR 10-Years
10%
Immatics NV
NASDAQ:IMTX
Revenue
€54m
CAGR 3-Years
20%
CAGR 5-Years
70%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Revenue
€707m
CAGR 3-Years
11%
CAGR 5-Years
12%
CAGR 10-Years
3%
Formycon AG
XETRA:FYB
Revenue
€77.7m
CAGR 3-Years
31%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

CureVac NV
Glance View

Market Cap
673m USD
Industry
Biotechnology

CureVac BV is a clinical-stage biopharmaceutical company, which engages in developing transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Tuebingen, Baden-Wuerttemberg and currently employs 500 full-time employees. The company went IPO on 2020-08-14. The firm is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The firm's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

CVAC Intrinsic Value
4.32 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is CureVac NV's Revenue?
Revenue
53.8m EUR

Based on the financial report for Dec 31, 2023, CureVac NV's Revenue amounts to 53.8m EUR.

What is CureVac NV's Revenue growth rate?
Revenue CAGR 5Y
33%

Over the last year, the Revenue growth was -20%. The average annual Revenue growth rates for CureVac NV have been 3% over the past three years , 33% over the past five years .

Back to Top